SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally is drawing attention to Starknets potential shift from an Ethereum Layer 2 to an independent Layer 1, alongside its privacy, Bitcoin DeFi and post-quantum security efforts. Traders are excited by the momentum and volume, while others warn of profit-taking, token-unlock pressure and pump-and-dump risk.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Attention centers on Midnights exchange access and network rollout, including the reported Coinbase listing and Google Cloud/Vodafone validator involvement, which bullish traders see as signs of growing adoption. Others remain cautious about weak price follow-through and selling pressure from token unlocks and airdrop distributions, alongside lingering concerns from the earlier bridge exploit.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives rally is being tied to ecosystem and access developments, including Solana integration, tokenized-asset activity, and ETF filings, while traders focus on a proposed supply-squeeze update that could increase INJ burns. Bulls see adoption and tighter supply as supportive, but others question the tokens value and warn the move may fade.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphases IQ Solid State Transformer development for AI data-center power, including U.S. manufacturing progress and planned demonstrations and pilots, has fueled renewed interest in the companys AI-energy prospects. Bulls see a potential growth driver and short-squeeze setup, while skeptics note that commercialization is still ahead and solar remains pressured by high borrowing costs and weak residential demand.

TOSHI

TOSHIs price action and repeated attempts to break resistance are drawing attention, with bullish traders anticipating a breakout or short squeeze and pointing to rising volume. Others remain skeptical, citing failed breakouts, prolonged weakness, and uncertainty about whether the communitys optimism will translate into sustained gains.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is drawing attention amid debate over prediction markets: traders point to rising DKeX volume and a bullish Bank of America upgrade as signs the platform could add revenue, while bears worry about competition from Kalshi and Polymarket and unresolved regulation. The conversation is sharply divided, with optimism about betting activity and DKeX growth set against frustration over the stocks decline, management, and profitability.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Bitcoin-driven volatility and COINs sharp, often lagging price swings dominate the discussion, with many traders frustrated that shares seem to fall with crypto but fail to match its rebounds. Views are split between buying the dip for a recovery and expecting further losses; some also point to analyst target hikes as support for the bullish case.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins volatile swings and tests of key support are driving discussion of MSTR, which traders view as a leveraged proxy for BTC. Bulls describe the pullbacks as buying opportunities and expect a rebound if Bitcoin stabilizes, while bears warn of further downside and cite shareholder dilution as an added risk.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL immunotherapy received its first marketing authorizations in Armenia for previously treated metastatic colorectal cancer, prompting discussion of a potential commercial foothold and possible interest from other countries. Traders are divided: some view the approval as an important validation and opening step, while others question the small market, expected revenue, and significance of approval by a smaller regulator.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

Anticipation around ASMLs upcoming earnings is driving discussion, with traders looking for guidance and signs that AI-related semiconductor demand remains strong. Optimists point to ASMLs role in chipmaking equipment, while others expect volatility or a pullback as investors await the report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Apollomics Stock Nosedived 16% After-Hours Today

Equity

The stock fell after-hours even after Nasdaq confirmed the biotech had regained compliance with listing standards.

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.

Apollomics Inc - Ordinary Shares - Class A

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

APLM News